PAHO/WHO | Pan American Health Organization

Concluye la 174ª Sesión del Comité Ejecutivo de la OPS con la aprobación de resoluciones para fortalecer la salud en las Américas

PAHO 174th session of the Executive Committee concludes with approval of resolutions to strengthen health in the Americas

Cristina Mitchell

28 Jun 2024

PAHO 174th session of the Executive Committee concludes with approval of resolutions to strengthen health in the Americas

Cristina Mitchell

28 Jun 2024

1 year 1 month ago

Health Archives - Barbados Today

QEH pharmacy extends opening hours ahead of potential bad weather

As Barbados braces for potential adverse weather associated with approaching tropical waves, the Queen Elizabeth Hospital (QEH) is advising patients who have prescriptions due within a week to get them refilled as soon as possible.

To facilitate this, the hospital pharmacy is extending opening hours Saturday, June 29, from 8:30 a.m. to 4 p.m., and it will also be open on Sunday, June 30 from 8:30 p.m. to 2 p.m., the QEH said in a statement.

Patients who have already placed orders through the Medication Delivery Service will have their medication delivered over the weekend.

Further information is available at the Patient Advice and Liaison Service (PALS/Help Desk) at 536-4800 from 9 a.m. to 9 p.m., via regular or WhatsApp calls.

The post QEH pharmacy extends opening hours ahead of potential bad weather appeared first on Barbados Today.

1 year 1 month ago

Health, Local News, News, Public Notice

Health – Dominican Today

EU approves first Chikungunya vaccine

Brussels.- The European Commission has authorized the first Chikungunya vaccine in the European Union for individuals over 18. This virus, transmitted by mosquito bites, is not currently endemic in the EU. However, climate change has increased the presence of mosquitoes that spread serious diseases.

Brussels.- The European Commission has authorized the first Chikungunya vaccine in the European Union for individuals over 18. This virus, transmitted by mosquito bites, is not currently endemic in the EU. However, climate change has increased the presence of mosquitoes that spread serious diseases. A recent report from the European Center for Disease Prevention and Control (ECDC) confirmed the presence of the tiger mosquito, capable of transmitting Chikungunya, in 13 EU and European Economic Area countries.

The vaccine has been approved for sale across the 27 EU countries following the European Medicines Agency’s endorsement. It is now up to individual governments to decide the conditions for its administration.

Additionally, the European Commission announced a €500,000 pilot program to eradicate the dengue mosquito in Cyprus, the only EU country where it has been found. This program will use the sterile insect technique, which involves releasing a large number of sterilized male insects to prevent female mosquitoes from reproducing.

1 year 1 month ago

Health

PAHO/WHO | Pan American Health Organization

New PAHO report shows NCDs continue as main cause of death and disability in the Americas, warns countries to prepare health systems for rapidly aging population

New PAHO report shows NCDs continue as main cause of death and disability in the Americas, warns countries to prepare health systems for rapidly aging population

Cristina Mitchell

28 Jun 2024

New PAHO report shows NCDs continue as main cause of death and disability in the Americas, warns countries to prepare health systems for rapidly aging population

Cristina Mitchell

28 Jun 2024

1 year 1 month ago

Health – Dominican Today

Third Latin American Congress on Digital Health

Santo Domingo.- Arium Salud Digital, a leading provider of digital services and tools for the health sector, in collaboration with AF Comunicación Estratégica, a public relations and corporate events firm, announces the third edition of the Latin American Digital Health Congress.

Santo Domingo.- Arium Salud Digital, a leading provider of digital services and tools for the health sector, in collaboration with AF Comunicación Estratégica, a public relations and corporate events firm, announces the third edition of the Latin American Digital Health Congress. The event, themed “Creating Health of the Future,” will be held on October 10, 2024, at the JW Marriott Santo Domingo hotel.

Experts will discuss the challenges and future of the health industry, emphasizing the impact of digital transformation and artificial intelligence.

“We are pleased to present this event that brings together the cutting edge of technology and medicine in our region. This year, our focus is on innovation, collaboration, and creating a healthier future through technology,” said Fedor Vidal, CEO of Arium Salud Digital.

Amelia Reyes Mora, president of AF Strategic Communication, highlighted the importance of maintaining these forums for networking and updates, demonstrating how e-health offers significant advantages and can address health system challenges.

The congress will gather health professionals, technology experts, and opinion leaders to explore the impact of technology on healthcare. The program will cover crucial topics to transform medical care in Latin America positively.

Held biennially, the congress has become a key driver of innovation, public-private collaboration, and modernization in the regional health sector. It focuses on strategies such as primary care and sector integration to improve accessibility, cost-effectiveness, and quality of medical care.

Previous editions saw over 450 participants, launched the country’s first digital health study, and promoted knowledge transfer.

Organizers promise a dynamic agenda featuring the latest trends in digital health, including conferences, interactive panel discussions, success stories, and networking opportunities.

The event targets managers and representatives from the health sector, technology, clinics and hospitals, health risk administrators (ARS), imaging centers, dentistry centers, pharmaceuticals, clinical laboratories, telecommunications, local and international insurance, and government sectors.

For registration and sponsorship information, visit the official page: https://congresosd.regfox.com/ 3er-congreso-latinoamericano- de-salud-digital

1 year 1 month ago

Health

Health | NOW Grenada

Norovirus is dominant causative agent of gastro outbreak

“To prevent the spread of norovirus, it is crucial to maintain good hand hygiene, adhere to food safety guidelines, and thoroughly disinfect contaminated areas”

1 year 1 month ago

Health, PRESS RELEASE, caribbean public health agency, carpha, CDC, centres for disease control and prevention, gastro, gastroenteritis, Ministry of Health, norovirus, paho, pan american health organisation, stomach flu

STAT

STAT+: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice

Sonia Vallabh always thought genome editing wouldn’t be an option. It was such an obvious solution that people invariably asked, “What about CRISPR?” at the end of talks. But the details never made sense.

Vallabh and her husband, Eric Minikel, scientists at the Broad Institute, have been racing to develop a treatment for prion disease, a rare form of neurodegeneration that killed her mother at age 51 and would, if left untreated, likely kill Vallabh as well. It’s an insidious disease. Although it can have several causes, in her case, a single genetic misspelling will lead neurons to produce misfolded versions of otherwise workaday proteins called prions. These mutant prions jump cell to cell, like viruses, misfolding other prions they touch and forming toxic, neuron-killing chains.

So why not use CRISPR to repair or remove the mutant gene?

Continue to STAT+ to read the full story…

1 year 1 month ago

Biotech, In the Lab, biotechnology, CRISPR, gene editing, Research, STAT+

Healio News

AI comparable to professional translation for patient discharges in some languages

When translating discharge instructions for pediatric conditions, machine translation platforms performed comparably to professional translations for Spanish and Portuguese but not Haitian Creole, a study found.One of the researchers told Healio that she became interested in the topic through firsthand experience after being born in the United States but growing up in Mexico and feeling “more c

omfortable speaking Spanish” with patients.“I was seeing my family and the patients that I care for encounter all of these barriers or others trying to access care,” Priscilla

1 year 1 month ago

Healio News

FDA gives accelerated approval to Epkinly for advanced follicular lymphoma

The FDA granted accelerated approval to epcoritamab-bysp for the treatment of adults with relapsed or refractory follicular lymphoma who have received two or more previous lines of therapy.Epcoritamab-bysp (Epkinly; Genmab, AbbVie) — a bispecific CD20-directed CD3 T-cell engager — received priority review and orphan drug designation from the FDA for the indication.

The agent received previous approval for adults with relapsed or refractory diffuse large B-cell lymphoma after two previous lines of therapy.FDA based accelerated approval on results from the open-label EPCORE NHL-1

1 year 1 month ago

Health | NOW Grenada

Invitation to Tender: G-CREWS Component 3.6 — Disaster Resilience in Medical Centres

G-CREWS 3.6 — Disaster Resilience in Medical Centres tender submissions shall be submitted electronically to the Public Procurement Board by Friday, 19 July 2024, no later than 3 pm

1 year 1 month ago

ADVERTISEMENT, Business, Environment, Health, and nuclear safety, bmu, g-crews, gcf, german development agency deutsche gesellschaft für internationale zusammenarbeit, german federal ministry for the environment, giz, gmbh, green climate fund, grenada climate resilient water sector project, medical centres, national water and sewerage authority, nature conservation, nawasa

STAT

Exclusive: European VC Forbion hires Dyne CEO, expands in US

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.

Read the rest…

1 year 1 month ago

Biotech, Business, Health, Pharma, Politics, The Readout, Biotech, biotechnology, Cancer, drug development, drug prices, drug pricing, FDA, finance, Medicare, Pharmaceuticals, Research

Healio News

VIDEO: Regenxbio offers updates on ABBV-RGX-314 programs

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Steve Pakola, MD, chief medical officer of Regenxbio, shares updates on the company’s retina programs.ABBV-RGX-314 (Regenxbio, AbbVie) “is well through a big chunk of our pivotal program for subretinal delivery for treatment of wet [age-related macular degeneration],” Pakola said.

“We’re also excited with the advance of our nonsurgical one-time in-office treatment via the suprachoroidal delivery program, which is evaluating this treatment for wet AMD but also for diabetic

1 year 1 month ago

News Archives - Healthy Caribbean Coalition

Hope for the Future

Youth from across the Caribbean are demanding healthier school food environments. On July 3rd – the first day of the 47th Regular Meeting of the Conference of Heads of Government of CARICOM – youth health advocates in The Bahamas, Barbados, Dominica, Jamaica, St. Lucia, and St.

Vincent and the Grenadines will initiate “Hope for the Future” – a significant gathering of key stakeholders in each territory to underscore the need for comprehensive school nutrition policies that regulate the sale and marketing of ultra processed products from school settings and are supported by octagonal front of package warning label to help school communities easily identify foods which should not be available in school settings. This is an essential strategy for building healthy and resilient communities. Notably, nearly 40 youth health advocates are leading the charge across participating countries.

Youth in Antigua and Barbuda, Grenada, Montserrat, St. Kitts and Nevis and Trinidad and Tobago will be hosting related activities to spotlight the issue. These events will serve as a compelling reminder to local and regional leaders of their commitment to implementing health-protecting strategies, including evidence-based healthy food policies. In line with the food and security thematic area of the Conference of Heads of Government of CARICOM, youth hope that healthy school nutrition policies will be considered and urgently implemented to ensure healthy school food environments are prioritized.

In February 2024, the Healthy Caribbean Coalition (HCC) and Healthy Caribbean Youth (HCY) organized “Caribbean Youth Voices in Health Advocacy Spaces – Healthy Food Policy Action,” in partnership with the Jamaica Youth Advocacy Network (JYAN), the Heart Foundation of Jamaica (HFJ), The Heart and Stroke Foundation of Barbados (HSFB), and UNICEF Jamaica. This three-day health policy-focused youth meeting added momentum to the efforts aimed at empowering the region’s youth to advocate for the implementation of Healthy Food Policies, including octagonal front-of-package nutrition warning labeling and restricting the availability and marketing of unhealthy products in school settings. Over 50 young people attended this event.

All children in the Caribbean deserve to learn and grow in healthy school environments that are not inundated with ultraprocessed products. It has been 17 years since the region’s leaders unified their vision for a healthier Caribbean through the Port of Spain Declaration. Now, it is time for them to revisit previous commitments, including healthier school food environments, #actonfacts and walk the talk for better nutrition in schools. They have the support of the region’s youth.
Danielle Walwyn
Advocacy Officer, HCC and Lead, Healthy Caribbean Youth (youth arm of the HCC)

The post Hope for the Future appeared first on Healthy Caribbean Coalition.

1 year 1 month ago

Healthy Caribbean Youth, News

Health – Dominican Today

Cedimat and Arajet partner to promote medical tourism

Santo Domingo.- Cedimat, a leading center for diagnostics, advanced medicine, and telemedicine conferences, has joined forces with Arajet, a prominent airline, to bolster medical tourism in the Dominican Republic.

Santo Domingo.- Cedimat, a leading center for diagnostics, advanced medicine, and telemedicine conferences, has joined forces with Arajet, a prominent airline, to bolster medical tourism in the Dominican Republic. This strategic partnership aims to showcase Cedimat’s state-of-the-art healthcare facilities and Arajet’s extensive flight network, making the country a preferred destination for international patients seeking advanced medical treatments.

Under the agreement, international visitors will gain access to Cedimat’s advanced medical expertise and cutting-edge technology, ensuring effective patient care in a comfortable and safe environment. Milagros Ureña, Cedimat’s General Director, emphasized the center’s longstanding commitment to providing quality healthcare with a focus on patient safety and compassion. This collaboration not only reinforces Cedimat’s mission to serve both local and global patients but also enhances the Dominican Republic’s reputation as a hub for medical tourism in the Caribbean and Central America.

Victor Pacheco Méndez, CEO of Arajet, highlighted the airline’s role in enhancing health tourism by facilitating direct and convenient travel options to the Dominican Republic. Arajet’s robust network of destinations will support increased accessibility for medical tourists, aligning with their goal to expand flight opportunities and contribute to the region’s healthcare industry. Through joint promotional efforts across multiple countries and destinations, Cedimat and Arajet are committed to driving economic growth while promoting the country’s advanced medical services on a global scale.

1 year 1 month ago

Health, tourism

Healio News

More triptan use linked to more acute treatment, hospital visits, health care costs

SAN DIEGO — Patients who used two or more triptans for migraine faced more acute treatment, more emergency-related hospital visits and higher medical costs compared with those who used one, data show.“Triptans are the most commonly prescribed acute treatment for migraine attacks,” Amit Bodhani, a researcher at AbbVie, and colleagues wrote in an abstract that was presented at the American Headac

he Society Annual Scientific Meeting. “However, not all patients have an adequate response to their initial triptan.”Bodhani and colleagues aimed to assess the burden of

1 year 1 month ago

PAHO/WHO | Pan American Health Organization

Nearly 1.8 billion adults at risk of disease from not doing enough physical activity

Nearly 1.8 billion adults at risk of disease from not doing enough physical activity

Cristina Mitchell

26 Jun 2024

Nearly 1.8 billion adults at risk of disease from not doing enough physical activity

Cristina Mitchell

26 Jun 2024

1 year 1 month ago

Health – Demerara Waves Online News- Guyana

Guyana now has large pool of physical therapists, expanding countrywide coverage

Guyana is now boasting a significant number of therapists, resulting in several countries being eager to learn about the strategy to do so, according to Director of Disability and Rehabilitation Services, Dr. Ariane Mangar. “People want what we have and they want to also learn how we were able to [achieve] such a remarkable feat ...

Guyana is now boasting a significant number of therapists, resulting in several countries being eager to learn about the strategy to do so, according to Director of Disability and Rehabilitation Services, Dr. Ariane Mangar. “People want what we have and they want to also learn how we were able to [achieve] such a remarkable feat ...

1 year 1 month ago

Health, News, countrywide coverage, National Disability Week, physical therapists

STAT

Intellia says its CRISPR-based therapy can be redosed

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. It’s Wednesday, which means it’a also “The Bear” season 3 premiere day. For my Boston readers, know that Ayo Edebiri has been thinking deeply about the tragedy of the Great Molasses Flood of 1919.

Read the rest…

1 year 1 month ago

Biotech, Business, Health, Pharma, Politics, The Readout, Biotech, biotechnology, drug development, drug prices, drug pricing, FDA, finance, Pharmaceuticals, Research

STAT

STAT+: Pharmalittle: We’re reading about rejection of an AbbVie Parkinson’s drug, PBM markups on mail order, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

So grab that cup of stimulation and get started. Our flavor today is mocha hazelnut, for those tracking our habits. Now, though, the time has come to get busy. So please grab your own cup and dig in to the items of interest assembled below. We hope you have a wonderful day, and please do keep in touch. …

For the second time, the U.S. Food and Drug Administration has declined to approve an AbbVie therapy for patients with Parkinson’s disease due to problems at a third-party manufacturer, Reuters writes. The company maintained that the agency had not identified issues with the therapy’s safety or efficacy and did not request additional trials. The therapy is a version of carbidopa-levodopa, the standard of care for the disease. It is administered subcutaneously, or under the skin, through an infusion pump in order to improve patients’ motor functions. If approved, analysts estimate $619.67 million in sales for ABBV-951 in 2026, according to LSEG data.

U.S. Sen. Jacky Rosen (D-Nev.) wants the U.S. Department of Health and Human Services to investigate why a low-cost generic cancer drug is not widely available to patients, The Hill reports. In a letter sent to the agency, Rosen questioned why Medicare patients pay $3,000 a month for abiraterone, a generic oral drug used as part of prostate cancer treatment, when a version that costs $171 is also on the market. The drug is sold by CivicaScript, a nonprofit that works with manufacturers to develop a drug and then partners with insurers, pharmacies, and pharmacy benefit managers to sell it to patients at a fraction of the price it would cost otherwise.

Continue to STAT+ to read the full story…

1 year 1 month ago

Pharma, Pharmalot, pharmalittle, STAT+

Pages